ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2020

Feb 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2020-02-06

Reporting Person: Shah Gaurav (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-06	Stock Option (Right to Buy)	$22.72	A	383306	Acquired	2030-02-06	Common Stock (383306)	Direct

Footnotes

F1: This option represents a right to purchase a total of 383,306 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 6, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.